Search
Close this search box.

Research News

IBS research news

IFFGD is a leader in the fight for more research to improve diagnostic and treatment options for gastrointestinal (GI) disorders. With donations from people like you, we directly fund grants and recognition awards to basic and clinical scientists working in the field.

With your input, we make the needs and concerns of people with functional GI and motility disorders known to the physicians, nurses, therapists, and researchers who work with patients and research these diseases. We have also fostered scientific exchange among leading researchers and clinicians through our International Symposium on Functional GI Disorders, and we collaborate on projects to evaluate the prevalence of these disorders and to determine the needs of those affected.

Learn More- Take Part

Share this page
Topics of this article
Was this article helpful?

IFFGD is a nonprofit education and research organization. Our mission is to inform, assist, and support people affected by gastrointestinal disorders.

Our original content is authored specifically for IFFGD readers, in response to your questions and concerns.

If you found this article helpful, please consider supporting IFFGD with a small tax-deductible donation.

Related Information
Medications for IBS

Any product taken for a therapeutic effect should be considered a drug. Use of medications for IBS, whether prescription, over-the-counter, herbs, or supplements should be

Read More »
Personal Stories
Medications for IBS

Any product taken for a therapeutic effect should be considered a drug. Use of medications for IBS, whether prescription, over-the-counter, herbs, or supplements should be

Read More »
Skip to content